Randomised Controlled Trial of Cisapride in Preterm Infants

Overview

Journal Arch Dis Child Fetal Neonatal Ed

Specialties Gynecology & Obstetrics
Pediatrics

Date 1999 Apr 22

PMID 10212076

Citations 8

Authors

R J McClure

J H Kristensen

A GRAUAUG

Affiliations

Soon will be listed here.

Abstract

Aim: To determine the effect of cisapride on gastrointestinal motility in preterm infants.

Methods: Cisapride (0.2 mg/kg, 8 hourly ) or placebo was given first for seven days in a double blind randomised crossover study of 10 preterm infants. Gastrointestinal motility was assessed on day 3 of each treatment. The half gastric emptying time (GET1/2) was determined by using ultrasonography to measure the decrease in the gastric antral cross sectional area after a feed. The whole gastrointestinal transit time (WGTT) was assessed by timing the transit of carmine red through the gut. Treatments were compared using the Wilcoxon matched pairs signed ranks test.

Results: Median (range) birthweight was 1200 (620, 1450) g and postconceptional age 33 (29, 34) weeks at recruitment. GET1/2 was significantly longer during cisapride treatment than during placebo; the median of the differences (95% confidence interval) was 19.2 (11, 30 minutes, p=0.008). WGTT was also longer during cisapride treatment, but the difference was not significant; the median of the differences was 11(-18, 52 hours, p=0.1).

Conclusions: Cisapride delays gastric emptying and may delay WGTT in preterm infants. Its use to promote gastrointestinal motility in this group cannot be recommended.

Citing Articles

Childhood gastroparesis is a unique entity in need of further investigation.

Febo-Rodriguez L, Chumpitazi B, Shulman R Neurogastroenterol Motil. 2019; 32(3):e13699.

PMID: 31407456 PMC: 7015769. DOI: 10.1111/nmo.13699.

Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature.

Tillman E, Smetana K, Bantu L, Buckley M J Pediatr Pharmacol Ther. 2016; 21(2):120-32.

PMID: 27199619 PMC: 4869769. DOI: 10.5863/1551-6776-21.2.120.

Pharmacological therapy of gastroesophageal reflux in preterm infants.

Corvaglia L, Monari C, Martini S, Aceti A, Faldella G Gastroenterol Res Pract. 2013; 2013:714564.

PMID: 23878533 PMC: 3710644. DOI: 10.1155/2013/714564.

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.

Tack J, Camilleri M, Chang L, Chey W, Galligan J, Lacy B Aliment Pharmacol Ther. 2012; 35(7):745-67.

PMID: 22356640 PMC: 3491670. DOI: 10.1111/j.1365-2036.2012.05011.x.

Cisapride treatment for gastro-oesophageal reflux in children.

Maclennan S, Augood C, Cash-Gibson L, Logan S, Gilbert R Cochrane Database Syst Rev. 2010; (4):CD002300.

PMID: 20393933 PMC: 7138252. DOI: 10.1002/14651858.CD002300.pub2.

References

Bergmann J, Chassany O, Guillausseau P, Bayle M, Chagnon S, Caulin C . Simultaneous noninvasive evaluation of gastric emptying and orocaecal transit times. Use in studying the actions of cisapride in diabetic patients. Eur J Clin Pharmacol. 1992; 43(2):121-4. DOI: 10.1007/BF01740656. View

Carroccio A, Iacono G, Li Voti G, Montalto G, Cavataio F, Tulone V . Gastric emptying in infants with gastroesophageal reflux. Ultrasound evaluation before and after cisapride administration. Scand J Gastroenterol. 1992; 27(9):799-804. DOI: 10.3109/00365529209011187. View

Newell S, Chapman S, Booth I . Ultrasonic assessment of gastric emptying in the preterm infant. Arch Dis Child. 1993; 69(1 Spec No):32-6. PMC: 1029394. DOI: 10.1136/adc.69.1_spec_no.32. View

Pan H, Galligan J . 5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol. 1994; 266(2 Pt 1):G230-8. DOI: 10.1152/ajpgi.1994.266.2.G230. View

Barone J, Jessen L, Colaizzi J, Bierman R . Cisapride: a gastrointestinal prokinetic drug. Ann Pharmacother. 1994; 28(4):488-500. DOI: 10.1177/106002809402800413. View

Lux G, Katschinski M, Ludwig S, Lederer P, Ellermann A, Domschke W . The effect of cisapride and metoclopramide on human digestive and interdigestive antroduodenal motility. Scand J Gastroenterol. 1994; 29(12):1105-10. DOI: 10.3109/00365529409094895. View

Cucchiara S, Raia V, Minella R, Frezza T, De Vizia B, De Ritis G . Ultrasound measurement of gastric emptying time in patients with cystic fibrosis and effect of ranitidine on delayed gastric emptying. J Pediatr. 1996; 128(4):485-8. DOI: 10.1016/s0022-3476(96)70358-x. View

Lewin M, Bryant R, Fenrich A, Grifka R . Cisapride-induced long QT interval. J Pediatr. 1996; 128(2):279-81. DOI: 10.1016/s0022-3476(96)70409-2. View

McClure R, Newell S . Effect of fortifying breast milk on gastric emptying. Arch Dis Child Fetal Neonatal Ed. 1996; 74(1):F60-2. PMC: 2528327. DOI: 10.1136/fn.74.1.f60. View

10.

Dieckmann K, Maurage C, Rolland J, Ramponi N, Jonville A . Torticollis as a side effect of cisapride treatment in an infant. J Pediatr Gastroenterol Nutr. 1996; 22(3):336. DOI: 10.1097/00005176-199604000-00022. View

11.

Al Tawil Y, Berseth C . Gestational and postnatal maturation of duodenal motor responses to intragastric feeding. J Pediatr. 1996; 129(3):374-81. DOI: 10.1016/s0022-3476(96)70069-0. View

12.

Bindl L, Buderus S, Ramirez M, Kirchhoff P, Lentze M . Cisapride reduces postoperative gastrocaecal transit time after cardiac surgery in children. Intensive Care Med. 1996; 22(9):977-80. DOI: 10.1007/BF02044127. View

13.

Lander A, Redkar R, Nicholls G, Lawson A, Choudhury S, Corkery J . Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial. Arch Dis Child Fetal Neonatal Ed. 1998; 77(2):F119-22. PMC: 1720698. DOI: 10.1136/fn.77.2.f119. View

14.

Enriquez A, Bolisetty S, Patole S, Garvey P, Campbell P . Randomised controlled trial of cisapride in feed intolerance in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998; 79(2):F110-3. PMC: 1720850. DOI: 10.1136/fn.79.2.f110. View

15.

Chen H, Goh M, Pan S . The effect and mechanism of the prokinetic action of cisapride on gastrointestinal smooth muscle. Gastroenterol Jpn. 1993; 28(2):218-23. DOI: 10.1007/BF02779223. View

16.

Greally P, Hampton F, MacFadyen U, Simpson H . Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux. Arch Dis Child. 1992; 67(5):618-21. PMC: 1793694. DOI: 10.1136/adc.67.5.618. View

17.

Rubaltelli F, Largajolli G . Effect of light exposure on gut transit time in jaundiced newborns. Acta Paediatr Scand. 1973; 62(2):146-8. DOI: 10.1111/j.1651-2227.1973.tb08082.x. View

18.

Gupta M, Brans Y . Gastric retention in neonates. Pediatrics. 1978; 62(1):26-9. View

19.

CAVELL B . Reservoir and emptying function of the stomach of the premature infant. Acta Paediatr Scand Suppl. 1982; 296:60-1. DOI: 10.1111/j.1651-2227.1982.tb09598.x. View

20.

Bisset W, Watt J, RIVERS R, Milla P . Ontogeny of fasting small intestinal motor activity in the human infant. Gut. 1988; 29(4):483-8. PMC: 1433530. DOI: 10.1136/gut.29.4.483. View